Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ANGO · against 557 other Healthcare companies listed in US-listed
Ranked #289 of 558 · scores higher than 47% of peers
Bars: peers in each 10-point band of the profitability score82 peers with a profitability score of 20–29, including ANGO · Click a bar to see the companies
Mainly because of its return on invested capital, return on assets and operating margin, which are weaker than most Healthcare peers.
| Metric | ANGO | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 517 reported | -22.2% | -7.0% | 40% | 33% | |
| Operating marginHigher is better · 479 reported | -11.2% | -2.4% | 42% | 33% | |
| Return on assetsHigher is better · 582 reported | -13.6% | -7.8% | 44% | 33% | |
| Return on equityHigher is better · 531 reported | -20.8% | -19.7% | 49% | Context only | |
| Gross marginHigher is better · 601 reported | 54.6% | 43.9% | 58% | Context only |
| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 595M USD | 99 | 97 | |
| 1 | 433M USD | 99 | 81 | |
| 1 | 17.9B USD | 99 | 76 | |
| 1 | 52.9B USD | 99 | 57 | |
| 1 | 578M USD | 99 | 73 | |
| 282 | 467M USD | 26 | 44 | |
| 282 | 200M USD | 26 | 30 | |
| 282 | 8.5B USD | 26 | 28 | |
| 289 | 4.1B USD | 25 | 39 | |
| 289 | 493M USD | 25 | 38 | |
| 289 | 533M USD | 25 | 36 | |
| 289 | 5.6B USD | 25 | 53 | |
| 289 | 1.9B USD | 25 | 44 | |
| 289 | 578M USD | 25 | 22 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score